Magnesium inhibits peritoneal calcification as a late-stage characteristic of encapsulating peritoneal sclerosis

[1]  D. Santoro,et al.  Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open Questions , 2023, Nutrients.

[2]  S. Yamada,et al.  Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD , 2023, Journal of atherosclerosis and thrombosis.

[3]  A. Davenport.  Calcium balance in peritoneal dialysis patients treated by continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) cyclers , 2023, Journal of Nephrology.

[4]  T. Kitazono,et al.  Glucose degradation products in peritoneal dialysis solution impair angiogenesis by dysregulating angiogenetic factors in endothelial and vascular smooth muscle cells , 2022, Clinical and Experimental Nephrology.

[5]  M. Tokumoto,et al.  Protective Roles of Xenotropic and Polytropic Retrovirus Receptor 1 (XPR1) in Uremic Vascular Calcification , 2022, Calcified Tissue International.

[6]  Yujun Du,et al.  Magnesium in renal fibrosis , 2022, International Urology and Nephrology.

[7]  Huige Peng,et al.  Anti-Fibrosis Effects of Magnesium Lithospermate B in Experimental Pulmonary Fibrosis: By Inhibiting TGF-βRI/Smad Signaling , 2021, Molecules.

[8]  M. Kuro-o.  Phosphate as a Pathogen of Arteriosclerosis and Aging , 2020, Journal of atherosclerosis and thrombosis.

[9]  A. Capucci,et al.  Impact on All-Cause and Cardiovascular Mortality of Cardiac Implantable Electronic Device Complications: Results From the POINTED Registry. , 2020, JACC. Clinical electrophysiology.

[10]  T. Kitazono,et al.  The glucose degradation product methylglyoxal induces immature angiogenesis in patients undergoing peritoneal dialysis. , 2020, Biochemical and biophysical research communications.

[11]  S. Bakker,et al.  Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification , 2019, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  Işıl Başara Akın,et al.  Computed Tomography Features of Encapsulating Peritoneal Sclerosis , 2019, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

[13]  H. Yoshida,et al.  Modified creatinine index and risk for cardiovascular events and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort study. , 2018, Atherosclerosis.

[14]  T. Takato,et al.  Long-term effects of low calcium dialysates on the serum calcium levels during maintenance hemodialysis treatments: A systematic review and meta-analysis , 2018, Scientific Reports.

[15]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[16]  T. Hewitson,et al.  Fetuin-A in the peritoneal effluent of patients with encapsulating peritoneal sclerosis-more than a protein? , 2017, Kidney International.

[17]  P. Brenchley,et al.  A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent. , 2017, Kidney international.

[18]  H. Yoshida,et al.  Modified Creatinine Index and the Risk of Bone Fracture in Patients Undergoing Hemodialysis: The Q-Cohort Study. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  C. Shanahan,et al.  Magnesium Counteracts Vascular Calcification: Passive Interference or Active Modulation? , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[20]  David W. Johnson,et al.  Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis — Position Paper for ISPD: 2017 Update , 2017, Peritoneal Dialysis International.

[21]  E. Peña,et al.  Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study , 2017, BMC Nephrology.

[22]  R. Joie.  WHAT HAVE WE LEARNED? , 2016, Alzheimer's & Dementia.

[23]  Hui Huang,et al.  MICS, an easily ignored contributor to arterial calcification in CKD patients. , 2016, American journal of physiology. Renal physiology.

[24]  M. Tokumoto,et al.  Fetuin-A decrease induced by a low-protein diet enhances vascular calcification in uremic rats with hyperphosphatemia. , 2015, American journal of physiology. Renal physiology.

[25]  H. Rakugi,et al.  Magnesium modifies the association between serum phosphate and the risk of progression to end-stage kidney disease in patients with non-diabetic chronic kidney disease. , 2015, Kidney international.

[26]  C. Giachelli,et al.  A current understanding of vascular calcification in CKD. , 2014, American journal of physiology. Renal physiology.

[27]  K. Masutani,et al.  Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. , 2014, American journal of physiology. Renal physiology.

[28]  A. Wang,et al.  Calcium Balance and Negative Impact of Calcium Load in Peritoneal Dialysis Patients , 2014, Peritoneal Dialysis International.

[29]  M. Bootman,et al.  Fetuin-A and Albumin Alter Cytotoxic Effects of Calcium Phosphate Nanoparticles on Human Vascular Smooth Muscle Cells , 2014, PloS one.

[30]  P. Bernardi.  The mitochondrial permeability transition pore: a mystery solved? , 2013, Front. Physiol..

[31]  C. Brenner,et al.  Physiological Roles of the Permeability Transition Pore , 2012, Circulation research.

[32]  T. Sakaguchi,et al.  The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients , 2012, International journal of nephrology and renovascular disease.

[33]  C. Shanahan,et al.  Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate , 2011, Circulation research.

[34]  H. Chung,et al.  Phosphate-Induced Apoptosis in Human Peritoneal Mesothelial Cells in vitro , 2011, American Journal of Nephrology.

[35]  E. Brown,et al.  Encapsulating peritoneal sclerosis: what have we learned? , 2011, Seminars in nephrology.

[36]  H. Hurst,et al.  Calcium and Magnesium Flux in Automated Peritoneal Dialysis , 2009, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[37]  J. Balligand,et al.  Nitric oxide synthase isoforms play distinct roles during acute peritonitis , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[38]  C. Reutelingsperger,et al.  Fetuin-A protects against atherosclerotic calcification in CKD. , 2009, Journal of the American Society of Nephrology : JASN.

[39]  W. Gedroyc,et al.  Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[40]  M. Nakayama,et al.  Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphology. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[41]  Z. Al-Aly,et al.  Aortic Msx2-Wnt Calcification Cascade Is Regulated by TNF-&agr;–Dependent Signals in Diabetic Ldlr−/− Mice , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[42]  H. Kawanishi,et al.  Successful Surgical Management of Encapsulating Peritoneal Sclerosis , 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[43]  O. Devuyst,et al.  Inhibition of Nitric Oxide Synthase Reverses Permeability Changes in a Mouse Model of Acute Peritonitis , 2005, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[44]  L. Schurgers,et al.  Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. , 2004, Journal of the American Society of Nephrology : JASN.

[45]  Y. Kawaguchi,et al.  Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  J. Woo,et al.  Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications? , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[47]  G. London,et al.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[48]  S. Moncada,et al.  Macrophage Endothelial Nitric-oxide Synthase Autoregulates Cellular Activation and Pro-inflammatory Protein Expression* , 2003, Journal of Biological Chemistry.

[49]  Y. Kawaguchi,et al.  Association between an Increased Surface Area of Peritoneal Microvessels and a High Peritoneal Solute Transport Rate , 2003, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[50]  J. Jimenez-Heffernan,et al.  Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. , 2003, The New England journal of medicine.

[51]  H. Koyama,et al.  Induction of Bone-Type Alkaline Phosphatase in Human Vascular Smooth Muscle Cells: Roles of Tumor Necrosis Factor-&agr; and Oncostatin M Derived From Macrophages , 2002, Circulation research.

[52]  Geraint T. Williams,et al.  Morphologic changes in the peritoneal membrane of patients with renal disease. , 2002, Journal of the American Society of Nephrology : JASN.

[53]  J. Blacher,et al.  Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease , 2001, Hypertension.

[54]  J. Miner.  Mystery solved , 2001, The Journal of cell biology.

[55]  F. Parhami,et al.  Tumor Necrosis Factor-&agr; Promotes In Vitro Calcification of Vascular Cells via the cAMP Pathway , 2000, Circulation.

[56]  B. Lindholm,et al.  Pathophysiology of Peritoneal Membrane Failure , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[57]  Y. Ubara,et al.  Severe ectopic calcification of the intestinal wall in a patient on long-term continuous ambulatory peritoneal dialysis therapy. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[58]  G. Kroemer,et al.  Disruption of the outer mitochondrial membrane as a result of large amplitude swelling: the impact of irreversible permeability transition , 1998, FEBS letters.

[59]  T. Ing,et al.  Hypomagnesemia in Continuous Ambulatory Peritoneal Dialysis Patients Dialyzed with a Low-Magnesium Peritoneal Dialysis Solution , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[60]  J. Winchester,et al.  Calcium and phosphate balance in dialysis patients. , 1993, Kidney international. Supplement.

[61]  Jr C. L. Webster.  The Implications , 2019, Autoethnography and Heuristic Inquiry for Doctoral-Level Researchers.

[62]  P. Fein,et al.  Serum magnesium concentration is a significant predictor of mortality in peritoneal dialysis patients. , 2014, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[63]  Y. Ha,et al.  A CROSS-SECTIONAL STUDY , 2010 .

[64]  K. Nitta,et al.  Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. , 2003, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.